Literature DB >> 15119015

Cloning of TLR3 isoform.

Eunjeong Yang1, Jeon-Soo Shin, Hyemi Kim, Hyoung Woo Park, Myoung Hee Kim, Se Jong Kim, In-Hong Choi.   

Abstract

Toll-like receptor (TLR) 3 is a member of the TLR family that confers innate immunity by recognizing viral pathogens. Herein, we report that the TLR3 isoform is expressed on human primary cells and cell lines. This isoform has 2,520 bp cDNAs compared to the 2,712 bp of full cDNA, is produced by deletion of an intron-like sequence within exon 4 and is co-expressed with wild type TLR3 in primary human astrocytes and glioblastoma cell lines. This finding suggests the TLR3 isoform in astrocytes may have a different immunological role for binding ligands during the immune response in brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15119015     DOI: 10.3349/ymj.2004.45.2.359

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  12 in total

1.  The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA.

Authors:  Monique Lafon; Françoise Megret; Mireille Lafage; Christophe Prehaud
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis.

Authors:  Markus Wörnle; Holger Schmid; Bernhard Banas; Monika Merkle; Anna Henger; Maximilian Roeder; Simone Blattner; Elisabeth Bock; Matthias Kretzler; Hermann-Josef Gröne; Detlef Schlöndorff
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  Toll-like receptor 3 regulates Mx expression in rare minnow Gobiocypris rarus after viral infection.

Authors:  Jianguo Su; Zuoyan Zhu; Yaping Wang; Jun Zou; Wei Hu
Journal:  Immunogenetics       Date:  2008-03-28       Impact factor: 2.846

4.  Secretion of the human Toll-like receptor 3 ectodomain is affected by single nucleotide polymorphisms and regulated by Unc93b1.

Authors:  Rongsu Qi; Scott Hoose; Jessica Schreiter; Kirti V Sawant; Roberta Lamb; C T Ranjith-Kumar; Juliane Mills; Lani San Mateo; Jarrat L Jordan; C Cheng Kao
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

5.  Toll-Like Receptor 9 Alternatively Spliced Isoform Negatively Regulates TLR9 Signaling in Teleost Fish.

Authors:  Frank Fang-Yao Lee; Hsiang-Chieh Chuang; Nai-Yu Chen; Govindarajulu Nagarajan; Pinwen Peter Chiou
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

6.  An inhibitory alternative splice isoform of Toll-like receptor 3 is induced by type I interferons in human astrocyte cell lines.

Authors:  Jin-Won Seo; Eun-Jeon Yang; Se Hoon Kim; In-Hong Choi
Journal:  BMB Rep       Date:  2015-12       Impact factor: 4.778

7.  Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies.

Authors:  Pauline Ménager; Pascal Roux; Françoise Mégret; Jean-Pierre Bourgeois; Anne-Marie Le Sourd; Anne Danckaert; Mireille Lafage; Christophe Préhaud; Monique Lafon
Journal:  PLoS Pathog       Date:  2009-02-27       Impact factor: 6.823

8.  Role of Toll-like receptors in adjuvant-augmented immune therapies.

Authors:  Tsukasa Seya; Takashi Akazawa; Tadayuki Tsujita; Misako Matsumoto
Journal:  Evid Based Complement Alternat Med       Date:  2006-01-30       Impact factor: 2.629

9.  Identification of Th1/Th2 regulatory switch to promote healing response during leishmaniasis: a computational approach.

Authors:  Piyali Ganguli; Saikat Chowdhury; Shomeek Chowdhury; Ram Rup Sarkar
Journal:  EURASIP J Bioinform Syst Biol       Date:  2015-12-01

10.  Global Proteomic and Methylome Analysis in Human Induced Pluripotent Stem Cells Reveals Overexpression of a Human TLR3 Affecting Proper Innate Immune Response Signaling.

Authors:  Jordi Requena; Ana Belen Alvarez-Palomo; Montserrat Codina-Pascual; Raul Delgado-Morales; Sebastian Moran; Manel Esteller; Martí Sal; Manel Juan; Anna Boronat Barado; Antonella Consiglio; Orleigh Addeleccia Bogle; Ernst Wolvetang; Dmitry Ovchinnikov; Inaki Alvarez; Dolores Jaraquemada; Jovita Mezquita-Pla; Rafael Oliva; Michael J Edel
Journal:  Stem Cells       Date:  2019-02-14       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.